Table 2.
Serum 25-hydroxyvitamin D status in patients with benign paroxysmal positional vertigo (BPPV) under rehabilitation therapy with and without supplemental vitamin D supplementation over 6 months follow-up duration
| BBPV groups | Types of treatment |
Baseline
Mean + SD |
Month 2
Mean + SD |
Month 6
Mean + SD |
|||
|---|---|---|---|---|---|---|---|
| Vitamin D deficient¥ (treatment group) (n=27) | Rehabilitationµ+vitamin D& | 11.4+1.9 | 0.001 | 34.2+3.3 | 0.88 | 35.5+2.9 | 0.35 |
| Vitamin D deficient (non-treatment group) (n=27) | Rehabilitation µ alone | 10.7+2.3 | 0.001 | 10.6+3 | 0.001 | 11.1+2.3 | 0.001 |
| Control (n=27) | Rehabilitation µ alone | 33.8+6.6 | - | 34.4+6 | - | 36.2+5.4 | - |
pβ
Compared with baseline
P*
Comparison with the control group by Student t test
¥
Serum 25-OHD < 20 mg/ml
µ
Epley therapy
&
Cholecalciferol 50.000 IU weekly for two months